long intergenic non-protein coding RNA 1975Genealiases: []
Q-omics provides the consensus-scored LINC01975 profile across patient tissues and cancer cell-line models. LINC01975 expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in KIRP. Among the 18 cancer types available for tumor–normal comparison, LINC01975 is differentially expressed in 10, with the highest sampling consensus in KIRC. Additionally, LINC01975 RNA expression shows 10,283 significant gene co-expression associations, with the highest sampling consensus in KICH. Together, these results highlight KIRP, KIRC, and KICH as cancer lineages where LINC01975 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01975 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01975 survival associations across molecular data types. LINC01975 RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01975 RNA expression–survival associations across cancer types. High LINC01975 expression shows unfavorable associations in UCS, but favorable associations in KIRP, LUAD, PAAD, ACC and KIRC. The KIRP Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify KIRP as the clearest survival context for LINC01975 RNA expression.
This table summarizes LINC01975 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01975. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01975 shows lower tumor expression in KIRC, THCA, COAD, KIRP and LUAD and higher tumor expression in BRCA. The KIRC box plot shows higher LINC01975 RNA expression in normal versus tumor tissue (log2 FC = −0.753, t-test p < 0.001).
This table shows molecular features associated with LINC01975 in patient tissues and cancer cell lines. In patient samples, LINC01975 shows the broadest associations at the RNA and protein expression levels, with KICH recurring as the lineage with the largest associated feature set.
